Hanmi Pharmaceutical Global Business Headquarters Accelerates Expansion into Canadian and US Markets, Strengthening Collaboration with Distribution Partner McKesson Introducing 'Countmate':...
SAN FRANCISCO, Feb. 13, 2025 /PRNewswire/ -- FLEX MARKETING, a dynamic new independent agency built to modernize the approach to...
Conference Call Scheduled for Friday, February 14 at 11:30 AM ESTNorthvale, New Jersey--(Newsfile Corp. - February 13, 2025) - Elite...
DH100 recognizes those companies that have helped make New York the capital of healthcare innovation NEW YORK, Feb. 13, 2025...
NEW YORK, Feb. 13, 2025 /PRNewswire/ -- Report with the AI impact on market trends - The ultraviolet (UV) sensor...
Real-Time PCR* Solution Combines an Assay and a Web Application for Rapid Strain Characterization to Quickly Identify Root Cause Contamination...
Kytopen announces expansion of its partnership program into Europe with its agreement with T-CURX GmbH, a biotech company based in...
Sedgwick brand protection releases year-in-review analysis of 2024 recall data MEMPHIS, Tenn., Feb. 13, 2025 /PRNewswire/ -- The number of...
CHADDS FORD, Pa., Feb. 13, 2025 /PRNewswire/ -- MOBILion Systems, Inc., a leader in separation science innovation, today announced its participation...
Participants to Enjoy Access to 24th Annual Bio-IT World Conference & Expo, Running Concurrently April 2-4 BOSTON, Feb. 13, 2025...
NEW YORK, Feb. 13, 2025 /PRNewswire/ -- Lindus Health, the "anti-CRO" running radically faster, more reliable clinical trials, has announced their...
Augustine Therapeutics appoints Gerhard Koenigas Chief Executive Officer as Company Prepares to Enter the Clinic Industry veteran Gerhard Koenig, PhD,...
RECORDATI: PRELIMINARY RESULTS FOR FULL YEAR 2024 REVENUE +12.4%, EBITDA(1) +12.5%, ADJUSTED NET INCOME(2) +8.4%PEAK YEAR SALES TARGETS RAISED FOR...
– Filed for Regulatory Approval of Mitapivat (PYRUKYND®) for the Treatment of Adult Patients with Non-Transfusion-Dependent and Transfusion-Dependent Alpha- or Beta-Thalassemia...
– ACTIVATE-Kids is the First Study to Demonstrate Efficacy of an Oral Therapy for Children with PK Deficiency Who Are...
--Company reported positive Phase 2b QUALITY study topline results for enobosarm + semaglutide (Wegovy®) with study meeting prespecified primary endpoint...
LONDON and RALEIGH, N.C., Feb. 13, 2025 (GLOBE NEWSWIRE) -- Verona Pharma plc (Nasdaq: VRNA) (“Verona Pharma” or the “Company”)...
VANCOUVER, British Columbia, Feb. 13, 2025 (GLOBE NEWSWIRE) -- Zymeworks Inc. (Nasdaq: ZYME), a clinical-stage biotechnology company developing a diverse...
Ad hoc announcement pursuant to Art. 53 LR AGAMREE® is the first product to receive an agreed federal price in...
CHICAGO, Feb. 12, 2025 /PRNewswire/ -- EVERSANA®, a leading provider of commercialization services to the life science industry, today announced its...